Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline versus CBT for generalized anxiety disorder
ISRCTN14845583Phase 4Terminated
- Sponsor
- University College London
- Start
- Jul 2015
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of sertraline in generalized anxiety disorder (GAD) (2 arms), sponsored by University College London. Primary endpoint: HADS-A. Started Jul 2015; status: terminated.
02
Drugs
sertraline
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on ISRCTN14845583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN14845583.